Our pipeline forms a robust portfolio of investigational
therapies in varied stages of clinical development.

Cancer Research

Hanmi is developing various innovative anticancer therapies that include the mutation-driven therapy, chemotherapy, bispecific antibodies, epigenetics, and immuno-oncology therapies. With these promising pipelines and their diverse combinations, Hanmi is trying to overcome this most complex disease for patients worldwide.